A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma

Autor: Nicolle, R, Gayet, O, Duconseil, P, Vanbrugghe, C, Roques, Julie, Bigonnet, M, Blum, Yuna, Elarouci, Nabila, Armenoult, L, Ayadi, M, de Reyniès, Aurélien, Puleo, Francesco, Augustin, J, Emile, J F, Svrcek, Magali, Arsenijevic, Tatjana, Hammel, P, Giovannini, M, Grandval, P, Dahan, Laeticia, Moutardier, V, Gilabert, M, Van Laethem, Jean-Luc, Bachet, J B, Cros, Jérôme, Iovanna, J, Dusetti, N J
Rok vydání: 2020
Předmět:
Zdroj: Annals of oncology
ISSN: 1569-8041
Popis: Chemotherapy is the only systemic treatment approved for pancreatic ductal adenocarcinoma (PDAC), with a selection of regimens based on patients' performance status and expected efficacy. The establishment of a potent stratification associated with chemotherapeutic efficacy could potentially improve prognosis by tailoring treatments.
info:eu-repo/semantics/published
Databáze: OpenAIRE